Fewer Injection Site Reactions In Patients Using AVONEX Versus Sub-cutaneous Interferon And Glatiramer Acetate For The Treatment Of Multiple Sclerosis
Links shared publicly online about this topic.
- 1,752total visits
Fewer Injection Site Reactions In Patients Using AVONEX Versus Sub-cutaneous Interferon And Glatiramer Acetate For The Treatment Of Multiple Sclerosis
Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon beta-1a IM) reported significantl
View full resource at medicalnewstoday.com
Tags: Skin, Multiple Sclerosis, Multiple Sclerosis Medication, Copaxone, Avonex, Rebif
Most Recently Shared on September 13, 2009 at 11:50 am By:
MedNewsToday: Fewer Injection Site Reactions In Patients Using AVONEX Versus Sub-cutaneous Interfer.. http://bit.ly/cBg1N
Advertisement
